Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akcea Therapeutics
Akcea Therapeutics
(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tegsedi
Inotersen
2018-10-05
2025-2031
Amyloidosis
,
Familial amyloid neuropathies
Waylivra
Volanesorsen
2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
cardiomyopathies
,
polyneuropathies
,
amyloid neuropathies
,
amyloidosis
,
familial amyloid neuropathies
,
alzheimer disease
,
immunoglobulin light-chain amyloidosis
,
pregnancy
,
familial amyloidosis
Pelacarsen
renal insufficiency
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
hypertriglyceridemia
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
hyperlipoproteinemias
,
homozygous familial hypercholesterolemia
Endocrine
neoplasm metastasis
,
prostatic neoplasms
,
carcinoma
,
carcinoid tumor
,
neuroendocrine carcinoma
,
breast diseases
,
hereditary sensory and autonomic neuropathies
,
endocrine gland neoplasms
,
islet cell carcinoma
,
malignant carcinoid syndrome
,
serotonin syndrome
,
recurrence
,
castration-resistant prostatic neoplasms
,
lobular carcinoma
,
ductal carcinoma breast
,
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
neuroendocrine tumors
,
male breast neoplasms
,
pancreatic neoplasms
,
heart failure
,
thalassemia
,
hypoglycemia
,
islet cell adenoma
,
multiple endocrine neoplasia type 1
,
iron overload
Trinessa
pneumonia
,
community-acquired pneumonia
Fluoroquinolone
healthy volunteers/patients
,
neoplasms
Thienopyridine
healthy volunteers/patients
,
acute coronary syndrome
,
coronary artery disease
,
atherosclerosis
,
percutaneous coronary intervention
,
myocardial infarction
,
st elevation myocardial infarction
,
non-st elevated myocardial infarction
Tqj230
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use